Abstract |
An 83-year-old Japanese woman was admitted to our hospital with severe hyponatremia ( sodium, 108 mEq/L [108 mmol/L]), hypokalemia, hypochloridemia, hypocalcemia, hypophosphatemia, and hypouricemia. Despite low plasma osmolarity (232 mOsm/kg [232 mmol/kg]), urine osmolarity (320 mOsm/kg) was greater than that of plasma, and she had increased urinary sodium excretion (88 mEq/L [88 mmol/L]) and an unsuppressed high plasma level of antidiuretic hormone (ADH; 5.5 pg/mL [5.1 pmol/L]). These findings indicated that she had syndrome of inappropriate ADH secretion ( SIADH). In addition, she had a generalized reabsorption defect of the proximal tubules, including decreased tubular reabsorption of phosphate, increased fractional excretion of uric acid, glycosuria despite a normal blood glucose level, and panaminoaciduria. Thus, combined SIADH and Fanconi syndrome was diagnosed. The cause was thought to be the antidepressant paroxetine, which is a selective serotonin reuptake inhibitor (SSRI). Several of the abnormal values resolved within 1 week after discontinuation of this drug. Although the precise mechanism responsible was not elucidated, we report an extremely rare case of combined SIADH and Fanconi syndrome, probably caused by short-term SSRI therapy.
|
Authors | Tomoko Ishii, Takayasu Ohtake, Takeo Yasu, Yasuhiro Kadotani, Shuji Hayashi, Machiko Oka, Kyoko Maesato, Tsutomu Mano, Ryota Ikee, Hidekazu Moriya, Shuzo Kobayashi |
Journal | American journal of kidney diseases : the official journal of the National Kidney Foundation
(Am J Kidney Dis)
Vol. 48
Issue 1
Pg. 155-8
(Jul 2006)
ISSN: 1523-6838 [Electronic] United States |
PMID | 16797399
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Serotonin Uptake Inhibitors
- Paroxetine
|
Topics |
- Aged
- Aged, 80 and over
- Fanconi Syndrome
(etiology, pathology)
- Female
- Humans
- Inappropriate ADH Syndrome
(etiology, pathology)
- Paroxetine
(adverse effects, therapeutic use)
- Selective Serotonin Reuptake Inhibitors
(adverse effects, therapeutic use)
|